However, the requirement to improve HER2 expression and gene amplification in gastric cancer has been also been indicated by a consortium of expert pathologists in other European countries (15,25,29), which is similar to the retrospective purpose of the present study. The gene discussed is ERBB2; the disease is gastric cancer.